BLTE Q4 2022 Earnings — Belite Bio, Inc Revenue & Financial Results | Market Cap Arena

BLTEBelite Bio, Inc

$7B

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$7M

Net Income

-$7M

EPS (Diluted)

$-0.30

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$1,483

Balance Sheet

Total Assets

$44M

Total Liabilities

$3M

Stockholders' Equity

$42M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$7M	-$2M	-168.9%
Net Income	-$7M	-$2M	-174.4%